EP Edge Journal Watch

In EP Edge Journal Watch – Issue 9 (February 2026) , we take a comprehensive, clinically grounded look at the evolving management of ventricular tachycardia (VT) —from last-line noninvasive therapies to next-generation devices, pharmacologic strategy, and infection prevention. This episode critically reviews the STRA-MI-VT trial , examining stereotactic arrhythmia radioablation (STAR) for refracto...

In EP Edge Journal Watch – Issue 8 (2026) , we deliver a comprehensive, evidence-driven analysis of the most important and practice-shaping studies in contemporary cardiac electrophysiology. This episode begins with ventricular tachycardia storm, examining why in-hospital mortality remains high despite aggressive rhythm control. We break down the CHAMPS score, focusing on patient selection, system...

EP-EDGE Journal Watch – Issue 7 (January 2026) Advanced Cardiac Electrophysiology Podcast | AF, DOACs, PFA, Devices & Heart Failure In EP-EDGE Journal Watch Issue 7 , Dr. Niraj Sharma delivers a high-impact, clinician-focused breakdown of the most practice-changing cardiac electrophysiology studies published in late 2025 and early 2026. This episode moves beyond headlines to translate data int...

EP Edge Journal Watch Podcast — Issue 6 (January 2026) Left Atrial Appendage Occlusion, AF Ablation Insights, Post-TAVR Conduction, ICU Anticoagulation & Translational EP Signals EP Edge Journal Watch is your high-yield, evidence-driven electrophysiology podcast—designed for busy clinicians who want clinical relevance, mechanistic insight, and practice-changing nuance without wading through ev...

EP Edge Journal Watch — January 2026 | Issue #5 Pulsed Field Ablation, Device Therapy, and the Era of Personalized EP Welcome to EP Edge Journal Watch – Issue #5 (January 2026) , your high-yield, evidence-driven electrophysiology podcast designed for practicing EPs who want more than just abstracts. As 2026 begins, electrophysiology is entering a defining phase—where pulsed field ablation (PFA) ma...

In this December 2025 episode of EP Edge Journal Watch , Dr. Niraj Sharma breaks down the most provocative atrial fibrillation trials of the year—studies that force us to rethink what really drives AF outcomes beyond the ablation lesion   EP EDGE JW Dec 2025 Newsletter. We dive deep into four game-changing themes shaping modern electrophysiology: Can we safely stop anticoagulation after AF ablatio...

Smartwatches are now among the most widely used heart-monitoring tools in the world — but how accurate are they really at detecting AFib? In this December 2025 Issue 3 of EP-Edge Journal Watch , Dr. Niraj Sharma, cardiologist and cardiac electrophysiologist, breaks down the strongest evidence to date on smartwatch AFib detection , Apple Watch ECG performance , false alerts , AF burden tracking , a...

In this special EP Edge Journal Watch episode, Dr. Niraj Sharma delivers a critical analysis of the landmark AQUATIC Trial , published in the New England Journal of Medicine (October 2025) . This pivotal study explores optimal antithrombotic strategies in patients with atrial fibrillation (AF) and coronary artery disease (CAD) — balancing ischemic protection with bleeding risk. Dr. Sharma dissects...

In this episode, Dr. Niraj Sharma breaks down six pivotal studies shaping today’s electrophysiology and cardiology practice—from lifestyle-driven AF control (ARREST-AF) and post-CABG atrial fibrillation management to the DOAC + aspirin conundrum in stable CAD, the return of digitoxin in HFrEF, insights from CABANA-Substudy, and the latest ICD registry data on shock rates. 

In this inaugural episode, Dr. Niraj Sharma breaks down three pivotal studies that could shift daily EP practice: How high-normal potassium targeting can reduce VT burden ( POT-CAST trial ). When GDMT withdrawal may be safe after recovery from tachycardia-induced cardiomyopathy. Why adverse pregnancy outcomes may predict long-term AF risk. Get the signal — not the noise — with expert analysis, cli...